A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients-Reference-Cited by-同舟云学术

A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients

Published:2021-12-15 Issue: Volume: Page:
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Bunthof Kim L. W.¹²,Al‐Hassany Linda³,Nakshbandi Gizal³,Hesselink Dennis A.⁴⁵,Schaik Ron H. N.⁶,ten Dam Marc A. G. J.⁷,Baas Marije C.¹,Hilbrands Luuk B.¹,Gelder Teun⁴⁸

Affiliation:

1. Department of Nephrology Radboud University Medical Center Nijmegen The Netherlands

2. Department of Internal Medicine Bravis Hospital Roosendaal The Netherlands

3. Department of Hospital Pharmacy Erasmus University Medical Center Rotterdam The Netherlands

4. Internal Medicine Division of Nephrology and Transplantation Erasmus University Medical Center Rotterdam The Netherlands

5. Erasmus University Medical Center Erasmus MC Transplant Institute Rotterdam The Netherlands

6. Clinical Chemistry Erasmus University Medical Center Rotterdam The Netherlands

7. Department of Internal Medicine Canisius Wilhelmina Hospital Nijmegen The Netherlands

8. Department of Clinical Pharmacy and Toxicology Leiden University Medical Center Leiden The Netherlands

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13206

Reference33 articles.

1. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report

2. Intra-patient variability in tacrolimus exposure: Causes, consequences for clinical management

3. High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation

4. Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure

5. Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between tacrolimus exposure and tremor, headache and insomnia in adult kidney transplant recipients: A systematic review;Transplantation Reviews;2024-01

2. Tacrolimus—why pharmacokinetics matter in the clinic;Frontiers in Transplantation;2023-08-21

3. Tacrolimus Exposure Before and After a Switch From Twice-Daily Immediate-Release to Once-Daily Prolonged Release Tacrolimus: The ENVARSWITCH Study;Transplant International;2023-08-01

4. CYP3A5 Polymorphism in Renal Transplantation: A Key to Personalized Immunosuppression;Transplantation Proceedings;2023-06

5. Tacrolimus Formulation, Exposure Variability, and Outcomes in Kidney Transplant Recipients;Progress in Transplantation;2022-12-23